✦ LIBER ✦

Risk-Based Monitoring: Implications of the US FDA Guidance for Pharmaceutical Physicians

✍ Scribed by Stoltz, Randall R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concentrations of prioritized pharmaceut

✍ Kostich, Mitchell S.; Batt, Angela L.; Lazorchak, James M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 236 KB

The use of belief-based probabilistic me

✍ Amy Donovan; Clive Oppenheimer; Michael Bravo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 851 KB

Implications of In-Use Photostability: P

✍ Baertschi, Steven W.; Clapham, David; Foti, Chris; Jansen, Patrick J.; Kristense 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

Use of prescribed and non-prescribed med

✍ Peri J. Ballantyne; Philippa J. Clarke; Joan A. Marshman; J. Charles Victor; Jud 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Use of prescribed and non-prescribed med

✍ Peri J. Ballantyne; Philippa J. Clarke; Joan A. Marshman; J. Charles Victor; Jud 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Monitoring presence, abundance and survi

✍ Chiari, Stefano; Zauli, Agnese; Audisio, Paolo; Campanaro, Alessandro; Donzelli, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 737 KB